TAK and 4502:JP Related Headlines
Go Back- Takeda Pharmaceutical (4502:JP) (TAK) PT Raised to JPY4,900 at JPMorgan
- Takeda Pharmaceutical (4502:JP) (TAK) PT Raised to JPY5,800 at CLSA
- Takeda Pharmaceutical (4502:JP) (TAK) PT Raised to JPY5,600 at BofA Securities
- Morgan Stanley Resumes Takeda Pharmaceutical (4502:JP) (TAK) at Overweight, 'Our second most preferred stock'
- Takeda Pharmaceutical (4502:JP) (TAK) PT Lowered to JPY5,000 at Macquarie
- Morgan Stanley Reiterates Overweight Rating on Takeda Pharmaceutical (4502:JP) (TAK)
- Takeda Pharmaceutical (4502:JP) (TAK) PT Lowered to JPY5,300 at Nomura/Instinet

